Description

CJC 1295 with DAC is a modified growth hormone releasing peptide examined for its prolonged activity in endocrine pathways. Researchers study how the DAC component supports sustained growth hormone signaling, metabolic balance, and peptide stability. Scientific models evaluate its influence on receptor interaction, hormonal release patterns, and metabolic regulation. Its extended half life makes it especially useful for controlled laboratory studies focused on long term endocrine activity.